Related Experiment Video
Updated: Sep 5, 2025

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
A content review of buprenorphine training programs for pharmacists
Scott A Davis1, Robyn Dryer1, William Zule2
1Division of Pharmaceutical Outcomes and Policy, University of North Carolina Eshelman School of Pharmacy, Asheville, NC, USA.
Objectives:
To identify and describe continuing education (CE) credit-bearing training programs for pharmacists that cover buprenorphine dispensing.
Methods:
Five CE databases were searched for trainings that were in English, targeted to pharmacists, addressed use of buprenorphine for opioid use disorder treatment, not state-specific, accredited by the Accreditation Council for Pharmacy Education, and available for online registration.
Results:
Twelve trainings met the inclusion criteria. The most common topics covered were background and statistical information (10 trainings) and the clinical role of buprenorphine in medication assisted therapy (9 trainings). No training covered all 10 topics assessed. Seven programs included content on prescribing barriers, but of those, only two briefly addressed buprenorphine dispensing barriers, and none addressed the widespread belief that the Drug Enforcement Administration sets limits on the amount of buprenorphine that can be ordered and stocked. A majority of the programs (75%) addressed the clinical details of treatment, but only five addressed social barriers, such as stigma.
Conclusion:
Future trainings should develop and increase pharmacists' awareness of content to address the gaps identified in this study so they can supplement existing trainings, especially related to DEA and wholesaler regulations and thresholds, communication, stigma, and ways of overcoming these.
Related Concept Videos
Drug Abuse and Addiction: Pharmacological Phenomena
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Drug Dependence
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Drug Regulation

